MedTrace Logo

A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction

NCT05316324 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 353

Last updated 2026-02-17

No results posted yet for this study

Summary

The researchers are doing this study to look at the number of complications that occur immediately after prepectoral breast reconstruction when Acellular Dermal Matrix (ADM) is used compared to when ADM is not used. These complications include infections, the need for Tissue Expander (TE) or implant removal, and other conditions that lead to additional surgery.

Conditions

Interventions

PROCEDURE

Prepectoral Breast Reconstruction with Acellular Dermal Matrix (ADM)

Prepectoral Breast Reconstruction with (ADM)

PROCEDURE

Prepectoral Breast Reconstruction without Acellular Dermal Matrix (ADM)

Prepectoral Breast Reconstruction without ADM

Sponsors & Collaborators

Principal Investigators

  • Evan Matros, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-23
Primary Completion
2027-03-31
Completion
2027-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05316324 on ClinicalTrials.gov